BioCentury | Apr 27, 2018
Company News

UCB buys rights to seizure candidate

...UCB S.A. (Euronext:UCB) acquired rights to intranasal midazolam (USL261) from the Proximagen LLC subsidiary of Acova...
...protein-2 (DPYSL2; CRMP-2). Acova Inc., Plymouth, Minn. UCB S.A., Euronext:UCB, Brussels, Belgium Business: Neurology Elizabeth S. Eaton Acova USL261 UCB...
BioCentury | Apr 20, 2018
Company News

UCB buys rights to seizure candidate

...UCB S.A. (Euronext:UCB) acquired rights to intranasal midazolam (USL261) from the Proximagen LLC subsidiary of Acova...
BioCentury | Oct 19, 2015
Company News

Cardiome, Mitsubishi Tanabe Pharma deal

...and Mitsubishi’s Mitsubishi Pharma Europe Ltd. subsidiary partnered to co-promote Cardiome’s Aggrastat tirofiban and Mitsubishi’s Exembol...
...of chest pain occurring within 12 hours and with ECG changes and/or elevated cardiac enzymes. Exembol...
BioCentury | Feb 27, 2014
Targets & Mechanisms

The XII factor

...ACS; angina angioplasty; percutaneous coronary intervention (PCI); thrombosis; thrombocytopenia Mitsubishi Tanabe Pharma Corp. (Tokyo:4508); GSK Arganova...
BioCentury | Nov 21, 2013
Targets & Mechanisms

Riding the integrin wave in thrombosis

...Co. and Mitsubishi Tanabe Pharma Corp. market the thrombin inhibitors Refludan lepirudin, Angiomax bivalirudin and Arganova...
BioCentury | Sep 2, 2013
Clinical News

Exembol argatroban regulatory update

...Scottish Medicines Consortium (SMC) reversed its November 2012 decision and now recommends the use of Exembol...
...analysis. The synthetic thrombin inhibitor is marketed as Argatra in Germany and Austria and as Novastan...
...Italy. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Product: Exembol argatroban ( Novastan , Argatra...
BioCentury | Apr 15, 2013
Clinical News

Novastan argatroban small molecule thrombin inhibitor data

...In a Phase III trial of Novastan as an anticoagulant in patients with a history of...
...of Thrombosis and Hemostasis meeting on June 12. Texas Biotechnology Corp. (TXB), Houston, Texas Product: Novastan...
BioCentury | Apr 15, 2013
Clinical News

Texas Biotech regulatory update

...The FDA granted priority review status for TBX's NDA for its Novastan ( argatroban ) thrombin...
...thrombin inhibitor. TBX and SmithKline-Beecham (Philadelphia, Penn.) last month agreed to market and co-develop Novastan...
BioCentury | Jul 16, 2012
Company News

Mitsubishi Tanabe Pharma sales and marketing update

...Mitsubishi's Mitsubishi Pharma Europe Ltd. subsidiary launched Exembol argatroban in the U.K. to treat heparin-induced thrombocytopenia...
...µg/kg/minute. The synthetic thrombin inhibitor is marketed as Argatra in Germany and Austria, and as Novastan...
BioCentury | Sep 22, 2008
Strategy

Biovitrum marketed products

...Rheumatoid arthritis (RA) Amgen Mimpara cinacalcet Second-generation calcimimetic Secondary hyperparathyroidism in advanced kidney disease Amgen Novastan...
Items per page:
1 - 10 of 62